Welcome, everyone. Thank you so much for joining us for this conversation about Moderna. My name is Courtney Breen. I am the U.S. pharma analyst here at Bernstein. And it is my privilege to have ...
An AI focus is essentially required from a tech company these days, and Microsoft knows that. But what exactly is in store at this year's conference? We have a few guesses, and some of the session ...
The problem is rarely about building the model itself, but when organizations try to weave AI into day-to-day business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results